COMMUNIQUÉS West-GlobeNewswire

Evogene Financial Results for the Second Quarter of 2018

18/07/2018 - 13:00

Earnings Announcement Schedule REHOVOT, Israel, July 18, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets, announced [...]

Catalyst Biosciences Announces Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors

18/07/2018 - 13:00

Interim data support goal of significantly reducing annualized bleed rates with daily subcutaneous injections of marzeptacog alfa (activated) Conference call and webcast to be held today, July 18, 2018 at 8:30 a.m. EDT [...]

Emblem Announces $3 Million Strategic Equity Investment in Natura Naturals and 9,000 kg Supply Agreement over three years

18/07/2018 - 12:30

TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (OTCBB:EMMBF) (“Emblem” or the “Company”), announced today that it is making a strategic equity investment (the “Equity Investment”) into [...]

Orion Group Half-Year Financial Report January-June 2018

18/07/2018 - 11:01

ORION CORPORATION HALF-YEAR FINANCIAL REPORT JANUARY-JUNE 2018 18 JULY 2018 at 12:00 EEST Orion Group Half-Year Financial Report January-June 2018 Orion's net sales for continuing operations in January-June 2018 [...]

Orion Corporation's financial reporting and Annual General Meeting in 2019

18/07/2018 - 10:01

ORION CORPORATION STOCK EXCHANGE RELEASE 18 JULY 2018 at 11.00 EEST Orion Corporation's financial reporting and Annual General Meeting in 2019 Orion Corporation will publish its Financial Statement Release 2018 on [...]

Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017

18/07/2018 - 08:27

Amsterdam, The Netherlands - 18 July 2018 Following earlier information provided regarding the delay on the publication of the Annual Report 2017 mainly due to technical issues which have now been identified, Esperite [...]

Novartis delivers solid growth in second quarter and continues transformation to a focused medicines company

18/07/2018 - 07:01

Net sales grew 5% (cc[1], +7% USD) mainly driven by: Cosentyx grew to USD 701 million, (+40% cc) with strong growth in all indications in the US and EU Entresto sales more than doubled to USD 239 million, (+113% cc) [...]

Novartis réalise une solide croissance au deuxième trimestre et poursuit sa transformation en une entreprise axée sur les médicaments

18/07/2018 - 07:01

Hausse du chiffre d'affaires net de 5% (tcc[1], +7% USD), stimulée principalement par: Cosentyx, qui a progressé à USD 701 millions, (+40% tcc), enregistrant une forte croissance dans toutes ses indications aux Etats- [...]

Rubius Therapeutics Announces Pricing of Initial Public Offering

18/07/2018 - 04:44

CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced the [...]

Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering

18/07/2018 - 00:55

SAN DIEGO, July 17, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Kane Biotech Announces Closing of Loan Transaction

18/07/2018 - 00:30

WINNIPEG, Manitoba, July 17, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced that it has received a loan (the “Loan”) in the amount of $500,000 [...]

Actinium Forms Nuclear Medicine Focused Advisory Board to Facilitate Pipeline Clinical Development and Iomab-B Commercial Planning

17/07/2018 - 23:30

NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN:ATNM) ("Actinium" or "the Company"), today announced that it has appointed the members of its Nuclear Medicine Clinical Advisory [...]

CorVel Announces Quarterly Earnings Release Webcast

17/07/2018 - 23:20

IRVINE, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast Hosts: Gordon Clemons, Chief Executive Officer Michael Combs, President Date: Tuesday, July 31 st , 2018 Time: 11:30 am EST. [...]

ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018

17/07/2018 - 22:30

LYON, France and CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) announced that its 2018 Annual General Meeting was held in Lyon on Thursday, June 28, 2018. At the [...]

Imagin Medical Reports Research Study Progress

17/07/2018 - 22:30

VANCOUVER, British Columbia and BOSTON, July 17, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) announced today favorable results in the 10- [...]

Cara Therapeutics Announces Proposed Offering of Common Stock

17/07/2018 - 22:23

STAMFORD, Conn., July 17, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]

AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares

17/07/2018 - 22:09

Lausanne, Switzerland, July 17, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced that it is commencing offerings of up to [...]

ICU Medical, Inc. Announces Time of Second Quarter 2018 Earnings Conference Call

17/07/2018 - 22:05

SAN CLEMENTE, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]

Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors

17/07/2018 - 22:05

WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]